O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+7.9%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$3.98B
AUM Growth
+$3.98B
(-4.5%)
Cap. Flow
-$356M
Cap. Flow
% of AUM
-8.96%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
122
New
13
Increased
19
Reduced
24
Closed
22
Top Buys
| 1 |
CAI
Caris Life Sciences, Inc. Common Stock
CAI
|
$81.1M |
| 2 |
UnitedHealth
UNH
|
$42.1M |
| 3 |
Roivant Sciences
ROIV
|
$31.3M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$22.4M |
| 5 |
CytomX Therapeutics
CTMX
|
$19.2M |
Top Sells
| 1 |
Pfizer
PFE
|
$97.6M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$76.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
$62.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$41.9M |
| 5 |
Xtant Medical Holdings
XTNT
|
$34.4M |
Sector Composition
| 1 | Healthcare | 99.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
X4 Pharmaceuticals
XFOR
$70M
| – | – |
-6,776,515
| Closed | -$1.6M |
|
|
SLRN
102
DELISTED
ACELYRIN
SLRN
| – | – |
-4,001,711
| Closed | -$9.88M |
|
103
BiomX
PHGE
$14.1M
| – | – |
-1,787,767
| Closed | -$993K |
|
|
104
Pfizer
PFE
$141B
| – | – |
-3,850,200
| Closed | -$97.6M |
|
105
NextCure
NXTC
$13.3M
| – | – |
-1,141,200
| Closed | -$548K |
|
106
Nkarta
NKTX
$149M
| – | – |
-821,400
| Closed | -$1.51M |
|
107
Invivyd
IVVD
$218M
| – | – |
-933,500
| Closed | -$565K |
|
|
108
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-2,540,136
| Closed | -$76.6M |
|
109
INmune Bio
INMB
$52.4M
| – | – |
0
| – | – |
|
110
Gilead Sciences
GILD
$140B
| – | – |
-197,500
| Closed | -$22.1M |
|
111
Fate Therapeutics
FATE
$115M
| – | – |
-1,680,580
| Closed | -$1.33M |
|
112
Cardiff Oncology
CRDF
$130M
| – | – |
-573,884
| Closed | -$1.8M |
|
113
AstraZeneca
AZN
$255B
| – | – |
0
| – | – |
|
114
Amgen
AMGN
$153B
| – | – |
-44,200
| Closed | -$13.8M |
|
115
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
116
Scholar Rock
SRRK
$3.3B
| – | – |
-151,800
| Closed | -$4.88M |
|
|
SWTX
117
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-950,200
| Closed | -$41.9M |
|
118
Instil Bio
TIL
$196M
| – | – |
-116,785
| Closed | -$2.03M |
|
119
Tango Therapeutics
TNGX
$745M
| – | – |
-550,000
| Closed | -$754K |
|
120
Vera Therapeutics
VERA
$1.47B
| – | – |
-481,065
| Closed | -$11.6M |
|
121
Verastem
VSTM
$585M
| – | – |
-2,862,448
| Closed | -$17.3M |
|